A House committee hearing on the Food and Drug Administration's progress toward implementing a federal law requiring it to develop a regulatory strategy for health information technology was postponed last Thursday as the government shutdown continued, according to an article on the Modern Healthcare website.
Dr. Jeffrey Shuren, director of the FDA's Center for Devices and Radiological Health, was scheduled to testify before the Health Subcommittee of the House Energy and Commerce Committee on the Food and Drug Administration Safety Innovation Act. Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, was also scheduled to testify at the subcommittee hearing.
The 2012 law requires HHS, through the FDA, and in consultation with the Office of the National Coordinator of Health Information Technology and the Federal Communications Commission, to develop "a proposed strategy and recommendations on an appropriate, risk-based regulatory framework pertaining to health information technology, including mobile medical applications, that promotes innovation, protects patient safety and avoids regulatory duplication," according to the article.
Read the article.
Building Envelope Design: Beyond Energy Efficiency
Outpatient Surge Reshapes Long-Term Strategy for Medical Outpatient Buildings
Mercy Medical Center to Be Integrated into Baystate Health
Managing IAQ in Healthcare Facilities During Wildfires
Building Hospital Resilience in an Era of Extreme Weather